Nabihah Tayob

4 articles listing Nabihah Tayob in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial Nature Communications
2. Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial Nature Communications
3. Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial Nature Communications
4. Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) Nature Communications